**Core Concept**
Methotrexate is a chemotherapeutic agent that acts as an antifolate drug, inhibiting dihydrofolate reductase (DHFR) enzyme. This enzyme is crucial for the synthesis of tetrahydrofolate (THF), which is necessary for DNA synthesis and repair. By blocking DHFR, methotrexate prevents the production of THF, leading to an accumulation of 5-phosphoribosyl-1-pyrophosphate (PRPP), which is then diverted away from nucleotide synthesis.

**Why the Correct Answer is Right**
Methotrexate is the primary treatment for choriocarcinoma, a type of gestational trophoblastic disease. It is administered either intramuscularly or subcutaneously, and its effectiveness is enhanced when combined with folic acid antagonists. Methotrexate's ability to inhibit DHFR makes it an ideal choice for targeting rapidly dividing cancer cells, such as those found in choriocarcinoma. Additionally, methotrexate's antifolate activity helps to prevent the growth of new blood vessels, further contributing to its efficacy in treating this condition.

**Why Each Wrong Option is Incorrect**
**Option B:** Actinomycin-D is a chemotherapeutic agent that works by intercalating DNA strands and inhibiting RNA synthesis, but it is not the primary treatment for choriocarcinoma. Actinomycin-D is more commonly used to treat Wilms' tumor and rhabdomyosarcoma.
**Option C:** Vincristine is a vinca alkaloid that works by inhibiting microtubule formation, thereby disrupting cell division. However, it is not the preferred treatment for choriocarcinoma and is more commonly used in combination with other agents to treat various types of cancer.
**Option D:** 6-thioguanine is a purine analog that is incorporated into DNA, leading to the inhibition of DNA synthesis. While it has some antineoplastic activity, it is not the primary treatment for choriocarcinoma and is more commonly used in combination with other agents to treat various types of cancer.

**Clinical Pearl / High-Yield Fact**
Methotrexate is a high-risk medication that requires careful monitoring of liver function and renal function. It is also essential to assess the patient's folate levels before initiating treatment, as low folate levels can increase the risk of methotrexate toxicity.

**✓ Correct Answer: A. Methotrexate**